Issued Patents All Time
Showing 1–25 of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12410225 | Modulation of dendritic cell lineages | Jan Tavernier, Anje CAUWELS, Lennart ZABEAU, Erik Depla | 2025-09-09 |
| 12364753 | CD8 binding agents | Jan Tavernier, Anje CAUWELS, Sarah Gerlo | 2025-07-22 |
| 12351614 | CLEC9A-based chimeric protein complexes | Erik Depla, Lennart ZABEAU, Jan Tavernier | 2025-07-08 |
| 12351633 | PD-1 and PD-L1 binding agents | Jan Tavernier, Lennart ZABEAU, Erik Depla | 2025-07-08 |
| 12091463 | Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH) | Jan Tavernier, Lennart ZABEAU, Erik Depla | 2024-09-17 |
| 12084497 | SIRP1α targeted chimeric proteins and uses thereof | Jan Tavernier | 2024-09-10 |
| 11896643 | Fibroblast binding agents and use thereof | Jan Tavernier, Anje CAUWELS | 2024-02-13 |
| 11753463 | Therapeutic targeting of non-cellular structures | Jan Tavernier, Leander HUYGHE, Anje CAUWELS | 2023-09-12 |
| 11702477 | Bi-functional chimeric proteins and uses thereof | Jan Tavernier, Leander HUYGHE, Thomas WUEEST | 2023-07-18 |
| 11661455 | Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety | Jan Tavernier | 2023-05-30 |
| 11566072 | CD8 binding agents | Jan Tavernier, Lennart ZABEAU, Erik Depla | 2023-01-31 |
| 11498966 | PD-1 and PD-L1 binding agents | Jan Tavernier, Lennart ZABEAU, Erik Depla | 2022-11-15 |
| 11440943 | Therapeutic interferon alpha 1 proteins | Erik Depla, Lennart ZABEAU, Jan Tavernier | 2022-09-13 |
| 11384154 | Targeted chimeric proteins and uses thereof | Jan Tavernier | 2022-07-12 |
| 11236166 | CD8 binding agents | Jan Tavernier, Anje CAUWELS, Sarah Gerlo | 2022-02-01 |
| 11236141 | Targeted mutant interferon-beta and uses thereof | Jan Tavernier, Frank Peelman | 2022-02-01 |
| 11084859 | Targeted mutant interferon-gamma and uses thereof | Jan Tavernier, Frank Peelman, Lennart ZABEAU | 2021-08-10 |
| 11001631 | Clec9A binding agents | Jan Tavernier, Anje CAUWELS, Sarah Gerlo | 2021-05-11 |
| 10988538 | Bispecific signaling agents and uses thereof | Jan Tavernier, Sandra VAN LINT, Anje CAUWELS | 2021-04-27 |
| 10906985 | Targeted engineered interferon and uses thereof | Lennart ZABEAU, Jan Tavernier | 2021-02-02 |
| 7135550 | Three hybrid assay system | Jon Come, Frank C. Becker, Christoph Reichel | 2006-11-14 |
| 5886149 | P53 response genes | Leonard Buckbinder, Randy Talbott, Bernd R. Seizinger | 1999-03-23 |
| 5872214 | NF2 isoforms | Bernd R. Seizinger, Albert Bianchi | 1999-02-16 |
| 5840673 | Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors | Leonard Buckbinder, Bernd R. Seizinger | 1998-11-24 |
| 5667987 | P53 response genes | Leonard Buckbinder, Randy Talbott, Bernd R. Seizinger | 1997-09-16 |